These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26006063)

  • 1. A Unified Probabilistic Framework for Dose-Response Assessment of Human Health Effects.
    Chiu WA; Slob W
    Environ Health Perspect; 2015 Dec; 123(12):1241-54. PubMed ID: 26006063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the RfD: Broad Application of a Probabilistic Approach to Improve Chemical Dose-Response Assessments for Noncancer Effects.
    Chiu WA; Axelrad DA; Dalaijamts C; Dockins C; Shao K; Shapiro AJ; Paoli G
    Environ Health Perspect; 2018 Jun; 126(6):067009. PubMed ID: 29968566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APROBA-Plus: A probabilistic tool to evaluate and express uncertainty in hazard characterization and exposure assessment of substances.
    Bokkers BGH; Mengelers MJ; Bakker MI; Chiu WA; Slob W
    Food Chem Toxicol; 2017 Dec; 110():408-417. PubMed ID: 29074418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of probabilistic methods to address variability and uncertainty in estimating risks for non-cancer health effects.
    Nielsen GH; Heiger-Bernays WJ; Levy JI; White RF; Axelrad DA; Lam J; Chartres N; Abrahamsson DP; Rayasam SDG; Shaffer RM; Zeise L; Woodruff TJ; Ginsberg GL
    Environ Health; 2023 Jan; 21(Suppl 1):129. PubMed ID: 36635712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a unified probabilistic framework to the dose-response assessment of acrolein.
    Blessinger T; Davis A; Chiu WA; Stanek J; Woodall GM; Gift J; Thayer KA; Bussard D
    Environ Int; 2020 Oct; 143():105953. PubMed ID: 32768806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Unified Probabilistic Framework for Cancer Risk Management.
    Rheinberger CM
    Risk Anal; 2021 Apr; 41(4):584-595. PubMed ID: 33340129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probabilistic framework for the estimation of the adult and child toxicokinetic intraspecies uncertainty factors.
    Pelekis M; Nicolich MJ; Gauthier JS
    Risk Anal; 2003 Dec; 23(6):1239-55. PubMed ID: 14641898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The probable future of toxicology - probabilistic risk assessment.
    Maertens A; Antignac E; Benfenati E; Bloch D; Fritsche E; Hoffmann S; Jaworska J; Loizou G; McNally K; Piechota P; Roggen EL; Teunis M; Hartung T
    ALTEX; 2024; 41(2):273-281. PubMed ID: 38215352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Probabilistic Dose-Response Assessment to Inform Risk-Based Decision Making.
    Chiu WA; Paoli GM
    Risk Anal; 2021 Apr; 41(4):596-609. PubMed ID: 32966629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unified approach to risk assessment for cancer and noncancer endpoints based on benchmark doses and uncertainty/safety factors.
    Gaylor DW; Kodell RL; Chen JJ; Krewski D
    Regul Toxicol Pharmacol; 1999 Apr; 29(2 Pt 1):151-7. PubMed ID: 10341145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of probabilistic exposure assessment and probabilistic hazard characterization.
    van der Voet H; Slob W
    Risk Anal; 2007 Apr; 27(2):351-71. PubMed ID: 17511703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the cancer slope factor: Broad application of Bayesian and probabilistic approaches for cancer dose-response assessment.
    Jang S; Shao K; Chiu WA
    Environ Int; 2023 May; 175():107959. PubMed ID: 37182419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A probabilistic effect assessment model for hazardous substances at the workplace.
    Schneider K; Schuhmacher-Wolz U; Hassauer M; Darschnik S; Elmshäuser E; Mosbach-Schulz O
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):172-81. PubMed ID: 16356615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probabilistic exposure analysis for chemical risk characterization.
    Bogen KT; Cullen AC; Frey HC; Price PS
    Toxicol Sci; 2009 May; 109(1):4-17. PubMed ID: 19223660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probabilistic dose-response modeling: case study using dichloromethane PBPK model results.
    Marino DJ; Starr TB
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):285-300. PubMed ID: 17949874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the use of hierarchical probabilistic models for characterizing and managing uncertainty in risk/safety assessment.
    Kodell RL; Chen JJ
    Risk Anal; 2007 Apr; 27(2):433-7. PubMed ID: 17511709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncertainty and variability in human exposure limits - a chemical-specific approach for ciprofloxacin and methotrexate.
    Oldenkamp R; Huijbregts MA; Ragas AM
    Crit Rev Toxicol; 2016; 46(3):261-78. PubMed ID: 26648512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the uncertainties in cancer risk assessment using the integrated probabilistic risk assessment (IPRA) approach.
    Slob W; Bakker MI; Biesebeek JD; Bokkers BG
    Risk Anal; 2014 Aug; 34(8):1401-22. PubMed ID: 24766324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mode of action-based probabilistic framework of dose-response assessment for nonmutagenic liver carcinogens: a case study of PCB-126.
    Zhou Y; Chen Q; Klaunig JE; Shao K
    Toxicol Sci; 2023 Nov; 196(2):250-260. PubMed ID: 37643630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian methods for uncertainty factor application for derivation of reference values.
    Simon TW; Zhu Y; Dourson ML; Beck NB
    Regul Toxicol Pharmacol; 2016 Oct; 80():9-24. PubMed ID: 27211295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.